Clinical Trials Browser

Phase 2 × benzamide × 1 year × Clear all

NCT04198922 2025-11-05

Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease

Phase 2 Active not recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT04720417 2025-07-15

Defactinib and VS-6766 for the Treatment of Patients With Metastatic Uveal Melanoma

Phase 2 Terminated

13 enrolled 13 charts

Uveal Melanoma